Knee Replacement Recalls
Knee replacement recalls have been issued because of loosening, early wear — meaning parts erode more quickly than expected — or packaging errors among. Manufacturers may voluntarily recall knee replacements when they discover a problem. In rare cases, the U.S. Food and Drug Administration can order a recall. But some defective knee implants are never recalled.
The advocacy group Consumers Union reviewed the FDA’s medical device database and found that 708 knee replacement recalls were issued between 2003 and 2018. Drugwatch conducted a separate review in 2018 and identified another 76 recalls. Roughly 97 percent of all recalls during that timeframe involved knee replacements from just three manufacturers: Zimmer-Biomet, DePuy and Stryker.
The recalls included nearly 250,000 package and label issues, knee implant parts and tools used in knee replacement surgery from 2014 through 2017 alone.
Smith & Nephew recalled more than 42,000 Journey I BCS Knee Systems in 2018 after joint registries in the United Kingdom and Australia — which collect data on joint replacement surgeries to improve patient care — reported the device’s revision surgery rates were 1.5 times that of the average for all knee replacements.
Manufacturers and Knee Replacement Safety
Knee implant manufacturers are responsible for appropriate marketing of their products. They must warn consumers and health care professionals about their devices’ risks.
Manufacturers are also responsible for monitoring their products for problems after FDA approval. But critics argue that the FDA approval process does not do enough to keep unsafe devices off the market.
Manufacturers often rely on the agency’s Premarket Notification process. This is also called the 510(k) process.
It lets knee replacement makers skip more rigorous tests. They only have to show their device is “substantially equivalent” to similar products.
Knee replacement lawsuits blame manufacturers for selling defective devices.
Reasons for Knee Replacement Recalls
Manufacturers issue knee replacement recalls for several reasons. These can be as simple as faulty packaging on knee replacement parts. Or they can involve defective parts that pose a risk of serious injuries.
- Faulty design
- Implants and tools were prone to fracture. Tools had flawed designs or sometimes fell into the surgical site
- Improper fit
- Implants could suffer damage when surgeons forced a component into place
- Patients needed revision surgery because knee replacements loosened
- Early wear
- Parts wore out sooner than expected
- Packaging errors
- Faulty packages compromised surgical tools’ sterility
- Co-mingled components
- Parts of the left and right knee replacements became mixed together. This caused confusion during surgery
Manufacturers with the Most Knee Replacement Recalls
Three manufacturers account for the majority of knee replacement recalls since 2003.
DePuy Synthes accounted for almost half of the total recalls.
Two other companies combined for only 19 recalls between them.
|Knee Replacement Manufacturer||Knee Recalls|
|Smith & Nephew||15|
DePuy Knee Replacement Recalls
DePuy Synthes has issued hundreds of recalls over the years.
One of the most recent was in December 2017 for Sigma knee components. The devices had higher than expected failure rates.
DePuy also recalled almost 14,000 Attune knee surgical tools in 2015. But to date, there have been no recalls of Attune Knee implants.
The FDA’s database shows at least six other DePuy knee replacement recalls since 2013.
Between 2003 and 2013, DePuy issued at least 477 knee replacement-related recalls. That’s more than any other knee implant manufacturer.
|December 2017||7,500||SIGMA HP PFJ Cemented Trochlear Implants||Elevated revision rates|
|January 2016||351||SIGMA HP MBT Non-Keel Punch Knee Instruments||Design flaw that could cause a delay in surgery|
|September 2015||7,488||Specialist 2 Intramedullary (SP2 IM) Rod||Instrument fracturing during surgery and leaving parts of the rods in patients|
|June 2015||13,964||Attune Knee Tibial Articulation Surface Instruments||Could come off during surgery, leaving a part in device in the patient|
|March 2015||28,732||LCS Complete RPS Inserts||Reports of higher revision surgery rates in Australia|
|November 2014||7,944||Attune Intuition Impaction Handle||Reports of fractures potentially leaving parts in the patient|
|November 2014||4,555||Attune Intuition Impactors||Could fracture and pieces could be left in the patient|
|February 2014||129||S-ROM Noiles Rotating Hinges||Defective packaging could compromise sterility|
Zimmer Biomet Knee Replacement Recalls
Zimmer Biomet has issued at least 355 knee replacement-related recalls since 2003.
One of the most recent was in 2017 for more than 28,000 joint components. Inspections found elevated endotoxin levels on the parts.
Zimmer Biomet is the largest knee-implant maker in the world. The company took on its present form with the merger of Zimmer and Biomet in 2015.
|November 2017||13,227||Gender Solutions Patello-Femoral Joint System||Packaging problems|
|November 2017||1023||Persona Partial Knee instruments||Spacer blocks do not fit in the alignment tower instrument or handle|
|October 2017||430||Persona Partial Knee Spacer Blocks||Problems with flexion in range-of-motion trials|
|February 2017||28,000||Zimmer Biomet polyethylene joint components||Elevated endotoxin levels|
|January 2017||15,000||Vanguard Total Knee System||Mislabeling and packaging problems|
|May 2016||10,256||Persona Trabecular Metal Tibial Plate Knee implants||Implant loosening|
|January 2016||42,064||Zimmer NexGen Knee implants||Packaging could adhere to implant parts|
Stryker Knee Replacement Recalls
Stryker issued 125 knee replacement-related recalls since 2003.
In 2016, the company issued two recalls affecting 14,000 surgical instruments.
|August 2016||2,039||Stryker Orthopaedics Patella Assembly Instruments||Parts could come apart from an accompanying instrument during surgery|
|June 2016||12,469||Modular Handle Triathlon Instruments||Parts could come apart from the rest of the instrument|
|September 2015||3,444||MIS Modular Distal Capture Triathlon Instruments||Reports that parts could come apart from the instruments|
|August 2014||1,147||Triathlon Femoral Components||Packaging issue could affect the shelf life of the devices’ sterility|
|August 2014||1,147||Scorpio Femoral Components||Packaging issue could affect the shelf life of the devices’ sterility|
Smith & Nephew Knee Replacement Recalls
Smith and Nephew has announced 15 knee replacement-related recalls since 2003.
The 2018 recall of the Journey I BCS Knee System affected more than 42,000 units, according to the FDA.
- JOURNEY BCS CoCr Femoral Component
- JOURNEY BCS Oxinium Femoral Component
- JOURNEY BCS Tibial Insert
Previous Smith & Nephew recalls involved fewer than 100 total units.
|June 2018||42,050||Journey I BCS Knee System||Higher than normal revision rates because of early component loosening and other problems|
|May 2017||46||Legion Tib Cone Impactor Heads||The wrong adhesive used in assembly|
|March 2016||24||TC-Plus Primary Tibial Components||Manufacturing defect; it could make the polyethylene insert difficult or impossible to seat during surgery|
|January 2016||8||Legion Hemi Stepped Tibial Screw-On Wedges||Screws were too long|
Wright Medical Knee Replacement Recalls
Wright Medical announced four knee replacement recalls since 2003. Drugwatch found none after 2013.
Wright sold its hip and knee division to Corin Orthopaedics in 2016 for a reported $290 million.
Wright is no longer a major player in the knee-implant business.
Arthrex Inc. Knee Replacement Recalls
Arthrex has issued two recalls related to its iBalance knee replacement line: one for the iBalance Total Knee Arthroplasty System and another for the iBalance Unicondylar Knee Arthroplasty System.
|December 2015||2,378||Arthrex iBalance TKA Tibial Tray||Outer metal surface was smooth compared to previous textured components|
|October 2017||20||iBalance(R) UKA, Femoral Cemented, Size 3, Left Medial/Right LATERAL||Incorrect part number printed on label|
Please seek the advice of a medical professional before making health care decisions.